TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT
Stanford University
Stanford University
Thomas Jefferson University
University of Alabama at Birmingham
University of Turin, Italy
Ohio State University Comprehensive Cancer Center
University of Rochester
M.D. Anderson Cancer Center
University of Southern California
City of Hope Medical Center
University Hospital, Brest